Presentation TCT 2012 Use of the REG1 Anticoagulation System During PCI May Improve Bleeding and Ischemic Complications Compared with Heparin: A PCI Substudy from the Phase 2B RADAR Trial Presenter: Thomas J. Povsic, John P. Vavalle, Laura H. Aberle, Steven L. Zelenkofske, Roxana Mehran, Mauricio G. Cohen, Christopher E. Buller, Jan H. Cornel, Jaroslaw D. Kasprzak, Gilles Montalescot, Peter Fail, Ian J. Sarembock, John H. Alexander January 03, 2012
News Daily News Rivaroxaban Continues Emergence of New Class of Anticoagulants for A-Fib Caitlin E. Cox September 14, 2011
News Daily News Prothrombin Works as Antidote to Rivaroxaban, Not Dabigatran L.A. McKeown September 13, 2011
News Daily News ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients Caitlin E. Cox August 10, 2011
News Daily News Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis L.A. McKeown April 15, 2011
News Daily News Vascular Stents an Option for Some Patients with Fibrosing Mediastinitis March 29, 2011
News Daily News Dabigatran Recommended as Alternative to Warfarin in A-fib Patients Jason Kahn February 13, 2011